Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on February 7, 2012. The report addresses a regulatory notice received from the NASDAQ Stock Market regarding the company's compliance with continued listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The only quantitative metric disclosed is the market capitalization threshold required for listing compliance.
- Minimum Market Value of Listed Securities Required: $35 million
- Compliance Status: Failed to meet the $35 million threshold for 30 consecutive business days.
Material Changes
The material event reported is the failure to satisfy NASDAQ Listing Rule 5550(b)(2). The company also failed to meet alternative requirements under Rules 5550(b)(1) or 5550(b)(3). Consequently, the company has been granted a compliance period to regain standing.
Outlook, Risks, and Contingencies
Compliance Period: NASDAQ has granted the company 180 calendar days, until August 6, 2012, to regain compliance.
Path to Compliance: The company must maintain a Market Value of Listed Securities of $35 million or more for a minimum of ten consecutive business days at any time during the compliance period.
Risks: There is no assurance the company will regain compliance. If the company fails to comply by the deadline, its securities will be subject to delisting. The company retains the right to appeal a delisting determination to a Hearings Panel.
Current Trading Status: The notice has no immediate effect on the listing or trading of the company's common stock.
Investor Verification Checklist
- Verify the current market capitalization of Oculus Innovative Sciences, Inc. to assess proximity to the $35 million threshold.
- Monitor the stock price daily to determine if the company can achieve ten consecutive days of closing above the required market value.
- Review the company's Annual Report on Form 10-K for additional risks and financial context not included in this 8-K.
- Confirm whether the company has filed any subsequent updates regarding its compliance status before the August 6, 2012 deadline.